- Neuro Omega™The Neuro Omega™ is the latest technological breakthrough in MER.
- Onsite DBS Therapy Consulting & SupportPlanning | Electrophysiological Mapping | Lead Placement
- NeuroSmartSmart Portable MER system with advanced target localization capabilities
- NeuroFortis™The NeuroFortis is an automatic, motorized, washable drive. Compatible with all Alpha Omega systems
- Autoclavable DriveThe Autoclavable Drive is a washable manual drive. Lightweight with low impact on frameless or frame based procedure
- AlphaLab SnR
The AlphaLab SnR revolutionizes the way neuroscience research is performed in the laboratory, making it the most advanced data acquisition system currently available on the market. The AlphaLab SnR is a comprehensive, fully integrated, high-throughput system that allows users to record and stimulate from a virtually endless number of channels, with unprecedented ease and flexibility. The system brings microelectrode recording to a new level–from passive observation to active control and sophisticated interaction with neural circuits.
- AlphaLab SnR + TBSIAlpha-Omega is offering, all-in-one data acquisition telemetry system used to record the neural activity of mid- to large-sized animal with unrestricted movement.
- EPS™ - Electrode Positioning SystemThe Alpha Omega EPS is a state-of-the-art micropositioner designed for the accurate placement of microelectrodes in acute in vivo experiments.
- FlexMT™Flexible microdrive designed with innovation in mind
- Scientific ConsumablesAlpha Omega has a complete line of single electrodes available to meet your research needs.
24 and 25 May 2018
Federation of European Neuroscience Societies - Science of Translation: Optimizing Animal Models for Neuropsychiatry
Translational research is an effective application of new knowledge, mechanisms, and techniques generated by advances in basic science research into new approaches for the prevention, diagnosis, and treatment of disease. It ties all scientists and specialties together- biologists, clinicians, from physiology to big data, granting a fantastic opportunity to share diverse views, solutions, and expectations for the future. Using multidisciplinary approaches when designing preclinical projects optimizes their translation from bench to bedside. In order to be accurate, strong, reliable and adequately-characterized animal models are needed to pioneer new therapeutic strategies that can, in turn, be implemented in the clinic. This is of utmost importance in the field of neuropsychiatric disorders
Santiago de Compostela, Spain
3 to 5 October 2018
LVI Reunión Anual SENFC - LVI Annual Meeting of the Spanish Society of Clinical Neurophysiology
The Organizing Committee is composed of members of the Clinical Neurophysiology Service of the University Clinical Hospital of Santiago de Compostela, as well as reference hospitals of the Galician Community.
Learn more by visit www.congresosenfc.com/senfc2018/introduction_en_66.php
7 to 11 July 2018
Federation of European Neuroscience Societies - FENS Annual Meeting 2018
FENS is Federation Of European Neuroscience Societies. FENS 2018 is organizing their 11th Annual Meeting from 7 July to 11 July. FENS Forum of Neuroscience is the largest international neuroscience meeting. FENS strives to promote excellence in neuroscience research in Europe at large and to facilitate the interaction between scientists in and outside Europe. Participants in the FENS Forums are scientists at all career levels working in all areas of neuroscience research.FENS 2018 will be held in Berlin, Germany. 5500 attendees will attend FENS 2018 Meeting this year.
12 to 15 November 2018
MEDICA 2018 - World Forum for Medicine
The world's leading trade fair for the medical industry invites you to Düsseldorf from 12 - 15 November 2018.
Learn more by visit www.medica-tradefair.com/
6 to 10 October 2018
Congress of Neurological Surgeons - 2018 Annual Meeting Overview
The 2018 CNS Annual Meeting breaks boundaries in delivering scientific discovery, interactive learning, and high-impact education directly relevant to your practice.
Learn more by visit www.cns.org/annual-meeting-2018
Maastricht University Medical Center
Director of Research at CNRS, Bordeaux, France
Beijing Institute of Functional Surgery and Xuanwu
Chief Investigator, Faculty of Medicine, Hebrew Un
Neurosurgeon, Hadassah Hospital, Jerusalem
MD, Boston MA.
Hofstra-North Shore LIJ School of Medicine, Presid
University of Toyama
Osaka University Graduate School of Frontier Biosc
University of Colorado
In the early 1990s Imad and Reem Younis, a married Arab couple from Nazareth who are graduates of Israel's premier engineering school, the Technion, began to develop proprietary tools to aid in locating the exact point in the brain to target, a problem that had been incredibly challenging. Given the obstacles the couple had to overcome – from breaking societal norms to being Arab Christians in a predominantly Jewish country – the company's rise is every bit as remarkable as its innovation.
Imad and Reem pursued neuroscience after graduating from the Technion, and in large part as a result of their interaction with Hagai Bergman and his research on the brain. In 1993, Bergman introduced the couple to Benabid, the godfather of deep brain stimulation. Eventually, the four began to collaborate. Imad got hooked because it's so rewarding. "Every time I see our devices," he says, "I am struck and say, 'Wow, this device really helps patients.'" As for Reem, helping those with Parkinson's is personal. Her father had the disease, and while he wasn't able to benefit from Alpha Omega's devices, Reem is thankful she's able to help others.
Alpha Omega devices act as a GPS inside the brain that guides doctors to the correct location for implanting a permanent electrode. Today, the devices are used in more than a hundred hospitals and 500 labs around the world. The company's sophisticated machinery is manufactured in Nazareth but marketed by its offices in the United States, Germany and Israel, as well as by representatives in China, Japan and Latin America.
The Younises attribute their success in large part to their very diverse group of engineers: Catholics, Protestants, Orthodox Christians, Muslims and Jews. "Imad and Reem Younis represent the rich diversity of the country's high-tech and start-up culture," says Israel's president, Reuven Rivlin. "They bring together all the communities in Israel with a shared vision for the future." Says Imad: "When we employ people from different cultures, we can go even farther because each one thinks differently," and this, he says, "can create innovation. We have the same father [Abraham]. We can work together to achieve common goals."
As the medical community discovers how to successfully treat various neurological diseases, Bergman and the Younises are now collaborating on what might be one of the biggest leaps in the history of deep brain stimulation. In 2015, they created a tool that places electrodes in the brain without human intervention. "You push the button and the system goes," says Bergman, who likens it to a driverless car. He dreams of creating devices that will replace humans for most surgery-related functions.
Being in the vanguard of their field is rewarding for Imad and Reem Younis. What's more rewarding, however, is knowing that their company has helped tens of thousands of people. As Reem puts it, "We return people back to life." There is no higher reward than that.
Alpha Omega Engineering received CFDA certificate for Neuro Omega - innovative Microelectrode Recording (MER) system used for advanced localization of surgical targets in Deep Brain Stimulation (DBS) for treatment of neurological and psychiatric disorders.
About Neuro Omega System
FDA cleared, Health Canada licensed, CE approved, and now CFDA registered Neuro Omega enables neurosurgeons to locate the optimal target for the implantation of Deep Brain Stimulation (DBS) Electrodes. The system can be used for advanced research needs as well.
“Alpha Omega Research and Development continues to set the pace for new and innovative hardware and software in the field of DBS navigation technologies which enhances the expansion of the procedure and widens its accessibility to all patients to improve their quality of life." - Imad Younis, President of Alpha Omega.
About Alpha Omega
Founded in 1993, Alpha Omega is a world-leading medical device company, specializing in neurosurgery and neuroscience. The company offers solutions for enhancing and simplifying Deep Brain Stimulation (DBS), by implementing sophisticated software and hardware for brain mapping and navigation.
Alpha Omega in China
Obtaining the CFDA Certificate for NeuroOmega is another significant milestone for Alpha Omega, that has already entered the Chinese market with NeuroNav (Compact MER solution) and established a genuine connection with Neurosurgeons and Neuroscientist communities. This is a colossal step towards Alpha Omega's growth in the China market.
Every year the Ministry for Economy and Industry, in cooperation with the Manufacturers Association and the Israel Export Institute, holds a ceremony at the President’s Residence to present awards to industrialists based on their achievements in the previous year.
The event took place last Sunday (8/7/18) at the President’s Residence, where ten navigators of Israeli Industry were honored with leadership awards within the framework of Israel’s 70th-anniversary celebrations.
This year Nazareth-born Technion graduates Reem and Imad Younis, co-founders of Alpha Omega, a global technological leader in Neuroscience and Functional Neurosurgery equipment were between the honorees.
President Reuven Rivlin said that new immigrants, native Israelis, Jews and Arabs imbued with blessed Israeli audacity and "chutzpah" have turned tiny Israel into an industrial, technological and innovative powerhouse.
Despite their diversity, he observed, the industries are linked by a thick cord of responsibility that the industrialists took upon themselves – to create places of employment and to integrate people from all strains of society, to provide for coming generations. “Industry builds a nation,” he said, “not only through profitable companies and innovative products but first and foremost through people.”
Alpha Omega made it a habit in taking part of the Technion Israel Institute of Technology Career Fair which happens twice a year - winter and spring semesters.
Among dozens of large and well known international companies, Alpha Omega had the privilege of taking part in this great and important event which strengthens Alpha Omega’s vision and values in the process of locating future talents to take upon the mission and the success of Alpha Omega for future generations.
The event was held on the 27th of December 2017 and Alpha Omega was stationed at booth number 60 in the upper level of the Churchill building. You can always check out our Career Page for new openings as we always strive to recruit qualified and exceptional individuals to join our team in one of our three global offices.
Alpha Omega congratulates the following individuals for winning the Regions Scholar Travel Awards to attend the 2017SfN Conference held in Washington D.C. during November 11th till November 15th.
- USA Region: Mahsa Malekmohammadi from the University of California at Los Angeles
- Europe Region: Javier Blesa from Integral A.C. Neuroscience Center HM CINAC of Madrid, Spain. Javier Blesa works at Dr. Jose Obeso’s Neuroscience Center where our AlphaLab Pro and AlphaLab SnR are used in the lab's Parkinson's Disease Research
- Asia Pacific Region: Mohamed Khateb from the Technion Institute of technology of Haifa, Israel